These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2873821)

  • 1. Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients.
    Christensen I; Geismar L; Kirkegaard A; Kirkegaard G
    Arzneimittelforschung; 1986 May; 36(5):855-60. PubMed ID: 2873821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients.
    Kirkegaard A; Kirkegaard G; Geismar L; Christensen I
    Arzneimittelforschung; 1981; 31(4):737-40. PubMed ID: 6113835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-statistical findings on irreversible chronic tardive dyskinesia caused by psychopharmaceuticals].
    Fiorillo A; Maietta A
    Acta Neurol (Napoli); 1977; 32(5):569-78. PubMed ID: 22222
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of diagnosis, hospital and sex on the effects of bromperidol].
    Woggon B; Fleischhauer J; Widmer A
    Int Pharmacopsychiatry; 1979; 14(4):213-27. PubMed ID: 42629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Side effects of methylperone in long-term therapy up to 8 years].
    Kirkegaard G; Kirkegaard A
    Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
    Barbato L; Monge A; Stocchi F; Nordera G
    Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-extrapyramidal motor side-effects in long-term therapy with neuroleptics: an analysis of 99 patients].
    Ginzel I; Hilger E; Barnas C
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):38-43. PubMed ID: 12407934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis in elderly patients: classification and pharmacotherapy.
    Mintzer J; Targum SD
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pharmacological management of aggressive and autoaggressive behaviour in mentally retarded patients with melperone (author's transl)].
    Hacke W
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Jan; 13(1):20-4. PubMed ID: 6102772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
    Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.